The Hidden Chaperones That Build RNA Silencing

For years, RNA interference has been described like a clean molecular trick: give a cell a small RNA, let Argonaute hold it, and watch the matching message disappear.

But biology is rarely that simple.

Thernablog.blogspot.com 

A new Nature study, “Structural basis for chaperone-guided assembly of RNA-induced silencing complex,” shows that RISC assembly is not merely RNA loading. It is a carefully staged folding event. Argonaute does not simply grab a small RNA duplex. It must first be opened, held, stabilized, loaded, folded, and released.

At the center of this story is Argonaute, the protein engine of RNA silencing. In mature RISC, Argonaute carries one guide RNA strand and uses it to recognize target mRNAs. But before that final state, the small RNA arrives as a bulky duplex. The mature Argonaute structure is too compact to easily accept such a duplex. So the cell uses molecular chaperones.

Lee and colleagues identify an AGO–HSP90–p23 complex, which they call the AGO maturation complex, or AMC. This complex captures Argonaute in an RNA-free, pre-loading state. In this state, HSP90 and p23 hold AGO2 in a dramatically open conformation. The N domain is pulled away from the PAZ–MID–PIWI module, creating a widened, positively charged cleft that can receive a small RNA duplex.

This is the key visual message of the paper: Argonaute must be opened before it can become RISC.

The study also changes how we think about RNA itself. The RNA duplex is not only cargo. It acts almost like a folding cofactor. A duplex with a proper 5′ phosphate promotes productive AGO folding, while single-stranded RNA does not. The 5′ phosphate is especially important because it engages the MID domain, helping define which strand will become the guide. Duplex length also matters, with 22–23 nucleotide duplexes supporting efficient folding.

This has direct implications for siRNA therapeutics. Many approved siRNA drugs depend on chemical modifications such as 2′-fluoro and 2′-O-methyl substitutions. The paper shows that some modification patterns are compatible with AGO folding, while others can impair it. In particular, changes at guide-strand positions 2, 6, and 14 can influence how well the RNA supports Argonaute maturation.

The broader lesson is powerful: siRNA potency is not determined only by sequence, stability, or target accessibility. It may also depend on whether the RNA can help Argonaute fold correctly during RISC assembly.

This study gives the field a structural snapshot of a previously elusive intermediate. It shows HSP90 and p23 acting not as passive helpers, but as architectural guides. They hold Argonaute open, prevent premature collapse, and create a landing zone for duplex RNA. Once RNA binds, Argonaute can fold into a functional pre-RISC, eject the passenger strand, and become the mature silencing machine.

For RNA biology, this is a beautiful mechanistic advance.

For RNA therapeutics, it is more than beautiful. It is practical.

The AMC may become a platform for testing which siRNA designs, terminal chemistries, duplex lengths, and chemical modifications best support RISC assembly. That could move siRNA design from empirical screening toward more rational, structure-guided engineering.

RNA silencing begins with a guide strand. But this paper reminds us that before a guide can guide, the protein must be built correctly.

And behind that process stands a hidden workshop of chaperones.

Why AlphaFold transformed protein biology, while RNA structure prediction remains one of biology’s most stubborn frontiers

 

TheRNABlog

RNA Function Follows Form — But RNA Refuses to Sit Still

The winner of the CASP14 protein-structure-prediction challenge was announced: AlphaFold, developed by Google DeepMind. The result was not merely better than previous tools. It was dramatically better. AlphaFold showed that artificial intelligence could predict many protein structures with near-experimental accuracy, solving a problem researchers had been chasing for decades.

Protein biology had its revolution.

RNA biology is still waiting for its equivalent moment.

That is the central tension behind Diana Kwon’s Nature Technology Feature, “RNA function follows form – why is it so hard to predict?” The article captures a frustrating truth: RNA is biologically essential, structurally fascinating, and increasingly important for medicine — but predicting its shape remains far harder than many people expected. 

RNA Is Not Just a Messenger

For decades, RNA was introduced in textbooks as a middleman: DNA stores genetic information, RNA carries the message, and proteins do the real work.

That explanation is now painfully incomplete.

RNA can regulate genes, catalyze reactions, guide protein complexes, control splicing, sense metabolites, organize cellular machinery, and influence disease. Ribozymes, riboswitches, long noncoding RNAs, microRNAs, guide RNAs, viral RNAs, circular RNAs, and therapeutic RNAs all remind us that RNA is not passive.

RNA does things.

But RNA does those things because it folds.

Its biological function depends on stems, loops, bulges, pseudoknots, junctions, long-range contacts, base stacking, ion coordination, and interactions with proteins or small molecules. In RNA biology, structure is not decoration. Structure is often the mechanism.

That is why the phrase “function follows form” matters.

An RNA molecule’s sequence tells us what it could become. Its structure tells us what it is actually capable of doing.

Why Proteins Were Easier for AI

AlphaFold’s success in protein structure prediction was built on several advantages.

Proteins have been studied structurally for a long time. Thousands of high-quality protein structures were already available in the Protein Data Bank. Protein sequences also carry rich evolutionary information: if two residues change together across evolution, they may physically interact in the folded protein. AlphaFold and related tools learned from these patterns at massive scale.

RNA does not offer the same easy path.

There are far fewer experimentally solved RNA structures than protein structures. Many RNAs are small, flexible, chemically sensitive, and structurally heterogeneous. RNA often depends on magnesium ions, cellular proteins, modifications, ligand binding, and environmental conditions to fold correctly. A sequence may not point to one stable structure. It may point to a shifting ensemble.

That makes RNA a much harder target for machine learning.

A protein often behaves like a molecule trying to reach a stable folded state.

RNA often behaves like a molecule negotiating among several states.

RNA’s Flexibility Is the Problem — and the Biology

The biggest mistake is to think RNA structure prediction is simply protein structure prediction with different building blocks.

RNA has its own grammar.

It has only four standard bases, but those bases can form canonical and noncanonical interactions. Its phosphate backbone is highly charged. Its folding can depend strongly on ions. It can form alternative secondary structures. It can switch conformations when binding a metabolite or protein. It can expose or hide regulatory regions depending on context.

This is not just a computational nuisance.

RNA flexibility is often exactly how RNA works.

A riboswitch must change shape to regulate gene expression. A viral RNA may remodel itself during infection. A guide RNA must fold into a form compatible with its protein partner. An mRNA may contain structural elements that affect translation, degradation, or immune recognition.

So the goal is not always to predict one “correct” RNA structure.

The goal may be to predict a population of possible structures, then understand which one matters under a specific biological condition.

That is much harder.

AlphaFold 3 Helps, But It Does Not End the RNA Problem

AlphaFold 3 expanded the modeling landscape by predicting biomolecular complexes involving proteins, DNA, RNA, small molecules, ions, and modified residues. That is a major advance because biology rarely happens molecule by molecule in isolation. Cells are crowded with interacting systems. 

But RNA structure prediction is still not solved.

AlphaFold 3 can model RNA-containing complexes, but RNA-only folding and RNA conformational ensembles remain difficult. Many RNA structures depend on experimental constraints, secondary structure priors, or specialized RNA-focused modeling approaches. The RNA field is therefore not simply waiting for one universal model to solve everything.

It is building a different toolkit.

The New RNA AI Toolkit

Several AI-based methods are now pushing RNA structure prediction forward.

Tools such as RhoFold+ use RNA language models and deep learning to predict RNA 3D structures from sequence. RhoFold+ was trained with large-scale RNA sequence information and designed to address the data scarcity that limits RNA modeling. 

Other methods, including trRosettaRNA and trRosettaRNA2, use RNA-specific structural logic, secondary structure information, and deep learning to improve 3D prediction. Recent work on trRosettaRNA2 emphasizes the value of secondary-structure-aware modeling and conformer prediction — a crucial feature because RNA often exists in multiple structural states rather than one fixed architecture. 

These methods suggest an important principle:

RNA prediction will probably not be solved by sequence alone.

It will require secondary structure priors, evolutionary signals, experimental probing data, cryo-EM maps, chemical constraints, molecular simulations, and AI models working together.

Experiments Still Matter

The rise of AI does not make RNA experiments obsolete.

It makes them more important.

Chemical probing methods such as SHAPE and DMS-based approaches can reveal which nucleotides are flexible, paired, exposed, or protected. Cryo-electron microscopy can capture larger RNA-containing complexes. NMR can reveal dynamics and local structure. X-ray crystallography can still provide atomic detail when crystals are available.

Each method sees a different part of the RNA story.

AI can propose models quickly. Experiments can test whether those models are real.

This is where RNA structure biology is heading: not toward purely computational prediction, but toward integrative structure determination.

A model becomes more trustworthy when it agrees with probing data, mutational analysis, cryo-EM density, biochemical function, and evolutionary conservation.

For RNA, evidence must converge.

Why This Matters for Medicine

RNA structure prediction is not just a technical problem for structural biologists. It is becoming central to biotechnology and medicine.

mRNA vaccines, siRNA drugs, antisense oligonucleotides, CRISPR guide RNAs, aptamers, ribozymes, circular RNAs, and self-amplifying RNAs all depend on folding behavior. A therapeutic RNA may fail because it folds incorrectly, exposes the wrong region, activates unwanted immune sensors, degrades too quickly, or binds inefficiently.

RNA-targeted small-molecule drugs are another major frontier. For a drug to bind RNA selectively, the RNA must present a recognizable structural pocket or motif. Without structural knowledge, RNA drug discovery becomes guesswork.

Better RNA structure prediction could help researchers design more stable RNAs, improve guide RNA performance, identify druggable RNA motifs, engineer riboswitches, and understand viral RNA elements.

In short, RNA structure prediction is not only about seeing molecules.

It is about designing them.

The Real Lesson from AlphaFold

AlphaFold changed protein biology because it made high-quality structural models widely accessible. It did not eliminate experiments, but it changed where experiments begin.

RNA needs a similar shift.

But the RNA version of that revolution may look different. It may not be a single model that predicts one final structure from sequence. It may be a network of tools that predicts secondary structures, tertiary folds, alternative conformers, RNA–protein complexes, RNA–ligand interactions, and experimentally testable structural hypotheses.

RNA does not sit still.

So RNA structure prediction must become comfortable with motion.

The next breakthrough will not simply tell us, “Here is the RNA structure.”

It will tell us:

Here are the structures this RNA can adopt. Here is when they appear. Here is what they bind. Here is how they regulate biology. Here is how we can redesign them.

That is the future RNA biology is moving toward.

Protein structure prediction had its AlphaFold moment.

RNA’s moment may be harder, slower, and messier.

But it may also be more interesting — because RNA is not merely a molecule with a shape.

It is a molecule with possibilities.

---

References / Sources

1. Kwon, D. “RNA function follows form – why is it so hard to predict?” Nature, 2025. (Nature)

2. Jumper, J. et al. “Highly accurate protein structure prediction with AlphaFold.” Nature, 2021. (Nature)

3. Abramson, J. et al. “Accurate structure prediction of biomolecular interactions with AlphaFold 3.” Nature, 2024. (Nature)

4. Shen, T. et al. “Accurate RNA 3D structure prediction using a language model-based deep learning approach.” Nature Methods, 2024. (Nature)

5. Wang, W. et al. “The trRosettaRNA server for RNA structure prediction.” Nature Protocols, 2026. (Yang Lab)

6. CASP16 RNA structure prediction assessment and Yang-Server/trRosettaRNA2 reporting. (Wiley Online Library)

RNA Folding Is Not Just Shape: The Principles That Make RNA Predictable

 

TheRNABLOG

RNA is often introduced as DNA's messenger, a disposable copy of genetic instructions. That picture is far too small. RNA can switch genes on and off, guide enzymes to genomic targets, catalyze reactions, scaffold protein assemblies, sense metabolites, and carry vaccine instructions into cells. It does these jobs not only through its sequence, but through the structures that sequence folds into.

That makes RNA folding one of biology's most useful prediction problems. If we can predict how an RNA molecule folds, we can begin to predict how it behaves. If we can design a sequence that folds into a chosen structure, we can build RNA tools for medicine, diagnostics, synthetic biology, and nanotechnology. The challenge is that RNA is not a rigid object. It is a restless molecule moving across an energy landscape, with useful structures competing against near-misses.

The Basic Rule: Pairing Creates Structure, But Energy Chooses The Fold

RNA is built from four bases: A, U, G, and C. The familiar base-pairing rules, A with U and G with C, allow a single RNA strand to fold back on itself. Stems form where complementary regions pair. Loops, bulges, internal loops, and junctions form where pairing is interrupted.

But the final fold is not chosen by base-pairing alone. It is chosen by the balance of free energy across all possible structures. A predicted "minimum free energy" structure is the one a model estimates to be most stable. Stacked base pairs usually stabilize RNA. Large loops, unstable junctions, weak stems, or awkward local motifs can destabilize it. Magnesium ions, temperature, proteins, ligands, chemical modifications, and the cellular environment can all shift the balance.

So the first principle is simple but powerful: RNA folding is competitive. The target fold must be more favorable than the alternative folds the same sequence can make.

The Second Rule: Local Motifs Can Make Or Break A Design

The paper attached to this prompt, Anderson-Lee et al.'s "Principles for Predicting RNA Secondary Structure Design Difficulty," focused on inverse folding: given a desired RNA secondary structure, can we find a sequence that folds into it? The study drew on Eterna, a citizen-science RNA design platform, where tens of thousands of players and multiple algorithms tested what makes RNA designs easy or difficult.

Their results show why folding prediction is also a design problem. Some target structures are easy to specify on paper but hard to realize in a real sequence. Short stems are a classic example. A two-base-pair stem may look harmless in a diagram, but it offers only a small number of stable sequence choices. If many short stems appear in the same design, the sequence often needs repeated mini-patterns, and repeated patterns can mispair with one another.

Bulges and internal loops create another problem. They interrupt stacking interactions, weakening the stem and making nearby alternative folds more competitive. Multiloops, where several stems meet, require careful tuning of closing base pairs and nearby loop energies. Zigzag-like arrangements of opposing bulges are especially difficult: they can make an otherwise straightforward RNA hard for algorithms to design.

This leads to a practical design rule from the Eterna community: the "principle of least elements." The fewer destabilizing or difficult motifs a target structure contains, the more likely it is to be designable.

The Third Rule: Symmetry Is Beautiful, But Dangerous

Human designers like symmetry. RNA often does not.

In RNA design, repeated stems, repeated loops, and exact visual symmetry can be traps. Repetition narrows the usable sequence space and increases the chance that one part of the molecule will pair with the wrong partner. A symmetric diagram may invite misfolded alternatives that are nearly as stable as, or more stable than, the intended fold.

This is one reason natural RNAs often show broken symmetry. They may contain repeated domains, but the repeated parts are not usually exact copies at the secondary-structure level. Small asymmetries can help prevent incorrect pairing while preserving the broader biological function.

For real-world design, this is a quiet but important lesson: do not confuse structural elegance with molecular reliability. A slightly irregular RNA may be easier to make, easier to predict, and more robust in cells.

The Fourth Rule: Prediction Needs Ensembles, Not Just One Fold

Many beginner explanations of RNA folding focus on one predicted structure. In real biology, that is rarely enough. RNA molecules occupy ensembles: collections of structures with different probabilities. Some RNAs need one dominant structure. Others need to switch between states, as riboswitches do when they bind metabolites. Still others need to keep a region unpaired so a protein, ribosome, guide RNA, or reverse transcriptase can access it.

That means useful prediction asks several questions:

-          What is the most likely fold?

-          What alternative folds are close in energy?

-          Which nucleotides are likely to be paired or unpaired?

-          How often does the molecule expose a functional site?

-          How stable is the RNA against chemical degradation?

-          How does the fold change when proteins, ligands, ions, or modifications are present?

High-throughput experiments have become essential here. Chemical probing methods such as SHAPE and DMS can measure which nucleotides are flexible or accessible across thousands of RNA molecules. These datasets can reveal where thermodynamic models succeed, where they fail, and how machine-learning models can improve prediction.

Why This Matters For Biological Applications

RNA folding prediction is not an academic exercise. It affects whether RNA technologies work outside a diagram.

In gene silencing, siRNAs and shRNAs must present the right guide strand and avoid structures that block loading into cellular machinery. In CRISPR genome editing, guide RNAs must preserve the scaffold structures needed for Cas protein binding while keeping the targeting region accessible. In riboswitch and biosensor engineering, the RNA must change structure reliably when it binds a molecule. In RNA nanotechnology, repeated tiles, junctions, and short stems must assemble without generating unwanted mispaired products.

For mRNA therapeutics and vaccines, folding affects translation, immune recognition, and degradation. RNA is chemically fragile; unpaired and flexible regions can be more vulnerable to hydrolysis. Models that predict local structure and degradation patterns can help design mRNAs that last longer while still being translated efficiently.

The most promising real-world strategy is therefore not "predict the perfect fold once." It is an iterative loop:

1. Choose a target function.
2. Propose structures that obey known designability rules.
3. Use computational tools to predict folds, ensembles, accessibility, and degradation risk.
4. Test many candidates experimentally.
5. Feed the results back into improved models.

This is already happening. Eterna-derived work has used community-designed RNA datasets to benchmark and improve folding packages. OpenVaccine-style efforts have combined RNA design and machine learning competitions to predict RNA degradation. The future of RNA engineering will likely come from this blend of physical modeling, high-throughput measurement, human intuition, and machine learning. 

The principles governing RNA folding are not just chemical rules; they are design rules. Stable stems help. Awkward loops, short repeated stems, dense difficult motifs, and exact symmetry can hurt. The best RNA designs respect the whole folding landscape, not just the desired final picture.

That is why RNA prediction is becoming so valuable for biology. It lets scientists ask, before entering the lab, whether a proposed RNA is likely to fold, switch, expose, bind, silence, guide, translate, or survive as intended. The more accurately we can answer those questions, the more RNA becomes a programmable material for living systems.

Sources

Anderson-Lee, J. et al. "Principles for Predicting RNA Secondary Structure Design Difficulty." Journal of Molecular Biology 428, 748-757 (2016). https://doi.org/10.1016/j.jmb.2015.11.013

Wayment-Steele, H. K. et al. "RNA secondary structure packages evaluated and improved by high-throughput experiments." Nature Methods 19, 1234-1242 (2022). https://doi.org/10.1038/s41592-022-01605-0

Wayment-Steele, H. K. et al. "Deep learning models for predicting RNA degradation via dual crowdsourcing." Nature Machine Intelligence 4, 1174-1184 (2022). https://doi.org/10.1038/s42256-022-00571-8

About 'The RNA Blog'

 

 About 'The RNA Blog' 

"The RNA Blog" is dedicated to exploring technological advancements in RNA biology and understanding its significance to all life forms and the future of humans. From time to time, I’ll share my thoughts on recent breakthroughs as well as noteworthy discoveries from the past on this topic. I’ll also highlight emerging concepts, novel research insights, and topics focused on RNA molecules useful to students, the scientific community, and bio-entrepreneurs.

Following topics will be discussed:

I. Core Concepts & Molecules:

• RNA (Ribonucleic Acid): The central molecule itself.
• Nucleotides: Adenine (A), Uracil (U), Guanine (G), Cytosine (C).
• Ribose: The sugar in the RNA backbone.
• Phosphate Backbone: Linking the nucleotides.
• Gene Expression: The overall process of using genetic information.
• Central Dogma: The flow of genetic information (DNA -> RNA -> Protein).
• Transcriptome: The complete set of RNA transcripts in a cell or organism at a specific time.
• Non-coding RNA (ncRNA): RNA molecules not translated into protein, often regulatory.
• Coding RNA: Primarily mRNA, which codes for proteins.

II. Major Types of RNA:

• Messenger RNA (mRNA): Carries genetic code from DNA to ribosomes for protein synthesis.
• Transfer RNA (tRNA): Delivers specific amino acids to the ribosome during translation.
• Ribosomal RNA (rRNA): Structural and catalytic component of ribosomes.
• Small nuclear RNA (snRNA): Involved in splicing (part of the spliceosome).
• Small nucleolar RNA (snoRNA): Guides chemical modifications of other RNAs (like rRNA, tRNA).
• MicroRNA (miRNA): Small ncRNAs that regulate gene expression post-transcriptionally, usually by silencing mRNA.
• Small interfering RNA (siRNA): Small ncRNAs involved in RNA interference (RNAi), often used experimentally or therapeutically to silence genes.
• Long non-coding RNA (lncRNA): Large ncRNAs with diverse regulatory functions (e.g., epigenetic regulation, scaffolding).
• Circular RNA (circRNA): Covalently closed RNA loops, often involved in regulation (e.g., miRNA sponges).
• Ribozyme: RNA molecules with catalytic activity.

III. Key Processes Involving RNA:

• Transcription: Synthesis of RNA from a DNA template (RNA Polymerase).
• RNA Processing: Modifications to RNA transcripts after transcription.
  • Splicing: Removal of introns and joining of exons (Spliceosome).
  • Capping: Addition of a modified guanine nucleotide to the 5' end of mRNA.
  • Polyadenylation: Addition of a poly(A) tail to the 3' end of mRNA.
  • RNA Editing: Alteration of nucleotide sequences within an RNA molecule.
• Translation: Synthesis of protein from an mRNA template (Ribosome, Codon, Anticodon).
• RNA Degradation/Turnover: Breakdown of RNA molecules (RNases, Exosome).
• RNA Interference (RNAi): Gene silencing pathway mediated by small RNAs (Dicer, RISC).
• Reverse Transcription: Synthesis of DNA from an RNA template (Reverse Transcriptase, Telomerase).
• RNA Transport/Localization: Movement of RNA molecules to specific cellular compartments.

IV. Structure, Modifications & Interactions:

• RNA Structure: Primary (sequence), Secondary (helices, loops, stems), Tertiary (3D folding), Quaternary (complexes).
• RNA Folding: The process by which RNA achieves its functional 3D shape.
• RNA Modifications (Epitranscriptomics): Chemical alterations to RNA bases (e.g., m6A, pseudouridine).
• RNA-Binding Proteins (RBPs): Proteins that bind to RNA and influence its processing, localization, stability, or translation.
• Ribonucleoprotein (RNP) Complex: Complexes formed by RNA and proteins (e.g., ribosome, spliceosome, telomerase, RISC).
• Riboswitch: Regulatory segments of mRNA that bind small molecules to control gene expression.

V. Research Areas & Techniques:

• Transcriptomics: Study of the transcriptome (often using RNA-Seq).
• RNA Sequencing (RNA-Seq): High-throughput sequencing to quantify and analyze RNA transcripts.
• RT-PCR / qPCR: Detecting and quantifying specific RNA molecules.
• Northern Blotting: Detecting specific RNA sequences.
• In Situ Hybridization (ISH): Visualizing RNA localization within tissues or cells.
• CLIP-Seq / RIP-Seq: Identifying RNA molecules bound by specific RBPs.
• Structural Biology of RNA: Determining RNA structures (X-ray crystallography, NMR, Cryo-EM).
• Bioinformatics: Computational analysis of RNA sequence, structure, and function.
• RNA Therapeutics: Using RNA molecules as drugs (mRNA vaccines, siRNA drugs, antisense oligonucleotides (ASOs)).